O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
Clinical trial NCT00275002 · COMPLETED
Trial details
- NCT number
- NCT00275002
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2010-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.